The Daily Pulse

Health

White House Claims Credit for Drop in Overdose Deaths Despite Earlier Declines Under Biden

Reported by Siddharth Deshmukh (Staff Writer) · NPR - Health ·

Source: NPR
Worth knowing
White House Claims Credit for Drop in Overdose Deaths Despite Earlier Declines Under BidenPhoto: Wikimedia Commons

Timing of the Decline

Data from the Centers for Disease Control and Prevention shows U.S. drug overdose deaths have dropped to their lowest level in about a decade, saving nearly 50,000 lives each year. While the White House released a statement claiming these gains happened mostly over the last 18 months due to President Trump's policies, drug policy researchers say the drop actually started much earlier.

Expert Findings

Reductions in drug deaths began in 2023 and have continued for at least 39 consecutive months, according to CDC data. Vanda Felbab-Brown from the Brookings Institution notes that declines began in the spring of 2023, and by the time President Biden left office, fatal overdoses had already dropped by roughly one-third. Researcher Nabarun Dasgupta from the University of North Carolina at Chapel Hill points out that the greatest rate of decline occurred from early 2024 through the spring of 2025.

Causes and Responses

Experts credit the Biden administration for expanding healthcare access, making the overdose drug naloxone more available, and reaching a deal with China to cut down shipments of chemicals used to make fentanyl. Fentanyl remains the leading cause of drug deaths nationwide after surging during the first two years of Biden's presidency and the COVID-19 pandemic.

White House and Cartel Claims

White House Office of National Drug Control Policy director Sara Carter credited heightened border security and efforts against narco-terrorist groups for a 41.5% decrease compared to the previous peak, while blaming the Biden administration for past high numbers. However, Felbab-Brown disputes that any major narco-terrorist organizations have actually been dismantled, noting they all continue to operate strongly.

Future Concerns

Dasgupta also warns that future progress could be at risk due to planned deep cuts to Medicaid passed by the Republican Congress. The Congressional Budget Office estimates these cuts could cause up to 10 million Americans to lose health insurance, which could threaten addiction services since Medicaid is the largest funder of those treatments in the United States.

Context

Public health data relies on long-term tracking by federal agencies to measure trends in substance use and mortality over many years. Changes in national drug policy, international supply chains, and domestic healthcare access all interact to influence public health outcomes across different presidential administrations.

ExplainerWhy this matters

What Happened

The White House and independent researchers disagree sharply over who deserves credit for a historic drop in U.S. drug overdose deaths, with officials pointing to recent Trump administration policies while data shows declines began years earlier under the Biden administration.

Why It Matters

Understanding the actual timeline of public health trends is crucial because researchers are trying to determine which specific interventions—such as international chemical controls, increased naloxone availability, or border enforcement—truly work. At the same time, upcoming policy changes like Medicaid funding cuts threaten to remove healthcare coverage for millions, which experts warn could reverse hard-won progress against the opioid epidemic.

What Happens Next

Researchers will continue to monitor mortality rates to see if the downward trend in overdose deaths can be sustained despite upcoming federal healthcare funding reductions, while lawmakers debate the future of border security and drug interdiction strategies.

Read more at NPR - Health →